BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3972833)

  • 1. Fluorescent phosphonate labels for serine hydrolases. Kinetic and spectroscopic properties of (7-nitrobenz-2-oxa-1,3-diazole)aminoalkyl methylphosphonofluoridates and their conjugates with acetylcholinesterase molecular forms.
    Berman HA; Olshefski DF; Gilbert M; Decker MM
    J Biol Chem; 1985 Mar; 260(6):3462-8. PubMed ID: 3972833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational change at the active center of serine-proteases upon their binding to alpha 2-macroglobulin.
    Martini JL; Pochon F
    Biochimie; 1989 Mar; 71(3):325-32. PubMed ID: 2472840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target sites for anticholinesterases on the ventral surface of the medulla oblongata: hypotension elicited by organophosphorus agents.
    Edery H; Geyer MA; Taylor P; Berman HA
    J Auton Pharmacol; 1986 Sep; 6(3):195-205. PubMed ID: 3771592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolving pathways of interaction of mipafox and a sarin analog with human acetylcholinesterase by kinetics, mass spectrometry and molecular modeling approaches.
    Mangas I; Taylor P; Vilanova E; Estévez J; França TC; Komives E; Radić Z
    Arch Toxicol; 2016 Mar; 90(3):603-16. PubMed ID: 25743373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of gelsolin with 4-fluoro-7-nitrobenz-2-oxa-1,3-diazole.
    Doi Y; Hashimoto T; Yamaguchi H; Vertut-Doï A
    Eur J Biochem; 1991 Jul; 199(2):277-83. PubMed ID: 1649046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
    Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
    Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic, equilibrium, and spectroscopic studies on dealkylation ("aging") of alkyl organophosphonyl acetylcholinesterase. Electrostatic control of enzyme topography.
    Berman HA; Decker MM
    J Biol Chem; 1986 Aug; 261(23):10646-52. PubMed ID: 3733723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reporter group delivery system with both absolute and selective specificity for thiol groups and an improved fluorescent probe containing the 7-nitrobenzo-2-oxa-1,3-diazole moiety.
    Stuchbury T; Shipton M; Norris R; Malthouse JP; Brocklehurst K; Herbert JA; Suschitzky H
    Biochem J; 1975 Nov; 151(2):417-32. PubMed ID: 3168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic, equilibrium and spectroscopic studies on cation association at the active center of acetylcholinesterase: topographic distinction between trimethyl and trimethylammonium sites.
    Berman HA; Decker MM
    Biochim Biophys Acta; 1986 Jul; 872(1-2):125-33. PubMed ID: 3089281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexibility of the molecular forms of acetylcholinesterase measured with steady-state and time-correlated fluorescence polarization spectroscopy.
    Berman HA; Yguerabide J; Taylor P
    Biochemistry; 1985 Dec; 24(25):7140-7. PubMed ID: 4084569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
    Maxwell DM; Brecht KM; Sweeney RE
    Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chiral nature of covalent methylphosphonyl conjugates of acetylcholinesterase.
    Berman HA; Decker MM
    J Biol Chem; 1989 Mar; 264(7):3951-6. PubMed ID: 2917984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-nitrobenz-2-oxa-1,3-diazole-4-yl-labeled phospholipids in lipid membranes: differences in fluorescence behavior.
    Mazères S; Schram V; Tocanne JF; Lopez A
    Biophys J; 1996 Jul; 71(1):327-35. PubMed ID: 8804615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxime-induced reactivation of acetylcholinesterase inhibited by organophosphinates.
    Hanke DW; Beckett MS; Overton MA; Burdick CK; Lieske CN
    J Appl Toxicol; 1990 Apr; 10(2):87-91. PubMed ID: 2362084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkaline structural transition of 4-nitrobenz-2-oxa-1,3-diazolyl-Lysozyme. Kinetic and spectroscopic investigations.
    Sigg RH; Luisi PL; Aboderin AA
    J Biol Chem; 1977 Apr; 252(8):2507-14. PubMed ID: 15990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site selectivity of fluorescent bisquaternary phenanthridinium ligands for acetylcholinesterase.
    Berman HA; Decker MM; Nowak MW; Leonard KJ; McCauley M; Baker WM; Taylor P
    Mol Pharmacol; 1987 Jun; 31(6):610-6. PubMed ID: 3600605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of oxime reactivation of acetylcholinesterase analyzed by chirality and mutagenesis.
    Wong L; Radic Z; Brüggemann RJ; Hosea N; Berman HA; Taylor P
    Biochemistry; 2000 May; 39(19):5750-7. PubMed ID: 10801325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel response of anion transporter in equine erythrocytes to a fluorescent substrate, N-(2-aminoethyl sulfonate)-7-nitrobenz-2-oxa-3-diazole (NBD-taurine).
    Inaba M; Goto I; Sato K; Maede Y
    J Vet Med Sci; 1993 Apr; 55(2):281-5. PubMed ID: 8513010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuning the hydrophobicity overcomes unfavorable deprotonation making octylamino-substituted 7-nitrobenz-2-oxa-1,3-diazole (n-octylamino-NBD) a protonophore and uncoupler of oxidative phosphorylation in mitochondria.
    Denisov SS; Kotova EA; Khailova LS; Korshunova GA; Antonenko YN
    Bioelectrochemistry; 2014 Aug; 98():30-8. PubMed ID: 24650997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.